FDA Extends Comment Period on Medical User Fee Program
The Food and Drug Administration is extending to November 1, 2010, the comment period for the notice that appeared in the August 13, 2010 Federal Register, in which FDA requested input and comments from interested stakeholders on FDA’s medical user…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
fee program and requested suggestions regarding the commitments FDA should propose for the next reauthorized program.